Skip to main content

Select Drug Profiles

Low-Cost Phone Intervention Helps with Weight Loss, Glycemic Control

Symptomatic hypoglycemia increases risk of cardiovascular events, death in type 2 diabetes

Progress in Cancer Care: Challenges and Opportunities

Dalia Buffery, MA, ABD

Increasing Importance of Oncology Drug Management for Payers

James T. Kenney, RPh, MBA

The Changing Face of Cancer Care: Evolution to a Collaborative Model

Michael Kolodziej, MD, FACP

Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases

Lisa A. Raedler, PhD, RPh

Kadcyla (Ado-Trastuzumab Emtansine): First Antibody-Drug Conjugate Approved for the Treatment of HER2-Positive Metastatic Breast Cancer

Lisa A. Raedler, PhD, RPh

Reflections on Japan’s Complex Medical Culture

David B. Nash, MD, MBA

Practice Management

Optimizing the Economic Impact of rtPA Use in a Stroke Belt State: The Case of South Carolina

Abby Swanson Kazley, PhD, Kit N. Simpson, DrPH, Annie Simpson, PhD, Edward Jauch, MD, Robert J. Adams, MD

Stakeholder Perspective

Stroking This South Carolina Model: Will It Play in Peoria?

by Albert Tzeel, MD, MHSA, CPE, FAAPL

Practice Management

The Race to Open Enrollment: Critical Success Factors for Exchanges

Caroline F. Pearson

Page 177 of 244
Results 1761 - 1770 of 2438